The introduction of nicotinamide as a nicotine substitute in e-cigarette and smokeless solutions signifies a substantial regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to act as a sedative at substantial dosages6. The claims produced by Nicotine River, ECBlend, as well as other sellers